-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 1, the website of the State Drug Administration released the "2021 Annual Drug Evaluation Report" (hereinafter referred to as the "Report.
The "Report" shows that in 2021, the Drug Evaluation Center of the State Drug Administration will accept 11,658 registration applications, a year-on-year increase of 179%; among them, 1,886 innovative drug registration applications (998 varieties) will be accepted, a year-on-year increase of 71
In 2021, a total of 12,083 registration applications will be concluded, a year-on-year increase of 15
In 2021, 2108 INDs were approved, a year-on-year increase of 490%; 323 NDAs were recommended for approval, a year-on-year increase of 529%; 1003 ANDAs were recommended for approval, a year-on-year increase of 26%; 1080 conformity evaluation applications were approved, a year-on-year increase of 81
Click the link below to view the full report
https://